治未病三伏贴对支气管哮喘缓解期患者冬病夏治的疗效观察(1)
摘 要：目的 观察治未病三伏贴对支气管哮喘缓解期患者冬病夏治的临床疗效。方法 选取2017年2月～2018年2月在我院治疗的100例支气管哮喘缓解期患者，随机分为对照组和观察组，每组50例。对照组采用传统贴膏治疗，观察组采用治未病三伏贴治疗，观察对比两组临床疗效、VCmax、FEV1、FEV1/FVC、红斑和水肿评分。结果 观察组治疗总有效率为94.00%，高于对照组的74.00%，差异有统计学意义(P<0.05)。治疗后，观察组VCmax、FEV1、FEV1/FVC等指标的改善优于对照组，差异有统计学意义(P<0.05)。观察组治疗后红斑、水肿评分低于对照组，差异有统计学意义(P<0.05)。结论 治未病三伏贴可提高支气管哮喘缓解期患者冬病夏控制率，改善患者肺功能，减轻临床症状，且临床皮肤反应轻，患者容易接受，利于临床的应用。
关键词：治未病；三伏贴；支气管哮喘；冬病夏治
中图分类号：R259 文献标识码：A DOI：10.3969/j.issn.1006-1959.2018.17.045
, 百拇医药
文章编号：1006-1959(2018)17-0143-03
Abstract：Objective To observe the clinical effect of preventive treatment of disease of Sanfu paster on winter disease and summer treatment in patients with bronchial asthma.Methods 100 patients with bronchial asthma remission who were treated in our hospital from February 2017 to February 2018 were randomly divided into the control group and the observation group，with 50 cases in each group.The control group was treated with traditional plaster，while the observation group was treated with Sanfu plaster.The clinical efficacy，VCmax，FEV1，FEV1/FVC，erythema and edema scores of the two groups were observed and compared.Results The total effective rate of the observation group was 94.00%，which was higher than that of the control group 74.00%，the difference was statistically significant (P<0.05).After treatment，the improvement of VCmax，FEV1，FEV1/FVC in the observation group was better than that in the control group，the difference was statistically significant(P<0.05).The erythema and edema scores in the observation group were lower than those in the control group，the difference was statistically significant(P<0.05).Conclusion Sanfu plaster can improve the control rate of asthma patients in summer and winter，improve the lung function，alleviate clinical symptoms，and the clinical skin reaction is light， patients are easy to accept，conducive to clinical application.
, 百拇医药
Key words：Preventive treatment of disease；Sanfu plaster；Bronchial asthma；Summer treatment of winter disease
支气管哮喘(bronchial asthma)是临床常见慢性呼吸道疾病，即使是缓解期，气道的高反应性仍然存在，严重影响患者的身体健康[1]。因为气道炎症和气道高反应性的存在，患者常常迁延不愈，容易反复发作，导致气道重构和不可逆肺功能损害。冬病夏治是中医的特色疗法之一，尤其是治疗支气管哮喘可以获得满意的疗效。夏季人体腠理疏松开泄、荣卫通达、便于药物吸收，采用穴位敷贴可提高机体非特异性免疫力，降低人体过敏状态[2]。加之中医药治疗与预防疾病已经成为当前临床的趋势，所以研究治末病三伏貼治疗支气管哮喘具有重要的临床意义。本文作者结合临床资料，在冬病夏治的基础上研究治末病三伏贴治疗支气管哮喘的疗效，为临床的应用提供可靠的理论基础，现报告如下。
1资料与方法
1.1一般资料 选取2017年2月～2018年2月在天津市武清区中医医院治疗的100例支气管哮喘缓解期患者为研究对象，本研究经医院伦理委员会批准。按照随机数字表法将其分为对照组和观察组，每组50例。对照组男性23例，女性27例；年龄20～63岁，平均年龄(41.02±4.78)岁；病程2～14年，平均病程(9.10±1.38)年；轻度20例，中度30例。观察组男性24例，女性26例；年龄19～62岁，平均年龄(40.75±5.01)岁；病程2～15年，平均病程(9.80±1.60)年；轻度18例，中度32例。两组患者在性别、年龄、病程等基础资料方面比较，差异无统计学意义(P>0.05)，具有可比性。, 百拇医药(井庆彦)
关键词：治未病；三伏贴；支气管哮喘；冬病夏治
中图分类号：R259 文献标识码：A DOI：10.3969/j.issn.1006-1959.2018.17.045
, 百拇医药
文章编号：1006-1959(2018)17-0143-03
Abstract：Objective To observe the clinical effect of preventive treatment of disease of Sanfu paster on winter disease and summer treatment in patients with bronchial asthma.Methods 100 patients with bronchial asthma remission who were treated in our hospital from February 2017 to February 2018 were randomly divided into the control group and the observation group，with 50 cases in each group.The control group was treated with traditional plaster，while the observation group was treated with Sanfu plaster.The clinical efficacy，VCmax，FEV1，FEV1/FVC，erythema and edema scores of the two groups were observed and compared.Results The total effective rate of the observation group was 94.00%，which was higher than that of the control group 74.00%，the difference was statistically significant (P<0.05).After treatment，the improvement of VCmax，FEV1，FEV1/FVC in the observation group was better than that in the control group，the difference was statistically significant(P<0.05).The erythema and edema scores in the observation group were lower than those in the control group，the difference was statistically significant(P<0.05).Conclusion Sanfu plaster can improve the control rate of asthma patients in summer and winter，improve the lung function，alleviate clinical symptoms，and the clinical skin reaction is light， patients are easy to accept，conducive to clinical application.
, 百拇医药
Key words：Preventive treatment of disease；Sanfu plaster；Bronchial asthma；Summer treatment of winter disease
支气管哮喘(bronchial asthma)是临床常见慢性呼吸道疾病，即使是缓解期，气道的高反应性仍然存在，严重影响患者的身体健康[1]。因为气道炎症和气道高反应性的存在，患者常常迁延不愈，容易反复发作，导致气道重构和不可逆肺功能损害。冬病夏治是中医的特色疗法之一，尤其是治疗支气管哮喘可以获得满意的疗效。夏季人体腠理疏松开泄、荣卫通达、便于药物吸收，采用穴位敷贴可提高机体非特异性免疫力，降低人体过敏状态[2]。加之中医药治疗与预防疾病已经成为当前临床的趋势，所以研究治末病三伏貼治疗支气管哮喘具有重要的临床意义。本文作者结合临床资料，在冬病夏治的基础上研究治末病三伏贴治疗支气管哮喘的疗效，为临床的应用提供可靠的理论基础，现报告如下。
1资料与方法
1.1一般资料 选取2017年2月～2018年2月在天津市武清区中医医院治疗的100例支气管哮喘缓解期患者为研究对象，本研究经医院伦理委员会批准。按照随机数字表法将其分为对照组和观察组，每组50例。对照组男性23例，女性27例；年龄20～63岁，平均年龄(41.02±4.78)岁；病程2～14年，平均病程(9.10±1.38)年；轻度20例，中度30例。观察组男性24例，女性26例；年龄19～62岁，平均年龄(40.75±5.01)岁；病程2～15年，平均病程(9.80±1.60)年；轻度18例，中度32例。两组患者在性别、年龄、病程等基础资料方面比较，差异无统计学意义(P>0.05)，具有可比性。, 百拇医药(井庆彦)